Compare Stocks: NXL, QTI, NEPH, and NTRB

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
NEPH Nephros	$3.51 +3.5%	$3.47	$2.66 ▼ $6.42	$36.80M	1.51	8,717 shs	58,160 shs
NTRB Nutriband	$2.81 -1.4%	$3.18	$2.81 ▼ $8.63	$34.65M	1.98	11,083 shs	5,602 shs
NXL Nexalin Technology	$0.36 +8.0%	$0.43	$0.31 ▼ $2.00	$7.44M	4	278,970 shs	350,777 shs
QTI QT Imaging	$2.63 -2.2%	$3.73	$1.55 ▼ $8.50	$37.04M	-0.01	39,650 shs	28,226 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
NEPH Nephros	0.00%	-6.87%	-0.29%	+12.40%	-0.85%
NTRB Nutriband	0.00%	-4.36%	-6.86%	-26.17%	-61.43%
NXL Nexalin Technology	0.00%	-29.80%	-6.43%	-11.18%	-65.84%
QTI QT Imaging	0.00%	-2.89%	-33.58%	-59.37%	+53.71%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
NEPH Nephros	$3.51 +3.5%	$3.47	$2.66 ▼ $6.42	$36.80M	1.51	8,717 shs	58,160 shs
NTRB Nutriband	$2.81 -1.4%	$3.18	$2.81 ▼ $8.63	$34.65M	1.98	11,083 shs	5,602 shs
NXL Nexalin Technology	$0.36 +8.0%	$0.43	$0.31 ▼ $2.00	$7.44M	4	278,970 shs	350,777 shs
QTI QT Imaging	$2.63 -2.2%	$3.73	$1.55 ▼ $8.50	$37.04M	-0.01	39,650 shs	28,226 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
NEPH Nephros	0.00%	-6.87%	-0.29%	+12.40%	-0.85%
NTRB Nutriband	0.00%	-4.36%	-6.86%	-26.17%	-61.43%
NXL Nexalin Technology	0.00%	-29.80%	-6.43%	-11.18%	-65.84%
QTI QT Imaging	0.00%	-2.89%	-33.58%	-59.37%	+53.71%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
NEPH Nephros	2.25	Hold	$5.00	42.45% Upside
NTRB Nutriband	1.50	Reduce	N/A	N/A
NXL Nexalin Technology	1.00	Sell	N/A	N/A
QTI QT Imaging	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest NXL, QTI, NEPH, and NTRB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/20/2026	NEPH Nephros	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/17/2026	NEPH Nephros	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Hold (C-)
7/17/2026	NEPH Nephros	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Market Perform	$4.00
7/10/2026	QTI QT Imaging	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/8/2026	NXL Nexalin Technology	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/1/2026	NTRB Nutriband	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/18/2026	NEPH Nephros	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
6/17/2026	NTRB Nutriband	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/4/2026	NEPH Nephros	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Hold (C-)
6/3/2026	NTRB Nutriband	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
5/21/2026	NEPH Nephros	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)

(Data available from 8/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
NEPH Nephros	$18.79M	2.03	$0.13 per share	27.02	$0.96 per share	3.66
NTRB Nutriband	$2.04M	16.75	N/A	N/A	$0.55 per share	5.11
NXL Nexalin Technology	$300K	26.77	N/A	N/A	$0.20 per share	1.82
QTI QT Imaging	$18.92M	1.91	N/A	N/A	$0.54 per share	4.87

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
NEPH Nephros	$1.19M	$0.07	50.15	18.47	N/A	4.06%	7.66%	5.86%	8/6/2026 (Estimated)
NTRB Nutriband	-$8.23M	-$2.58	N/A	N/A	N/A	-448.25%	-112.64%	-97.86%	9/30/2026 (Estimated)
NXL Nexalin Technology	-$8.22M	-$0.47	N/A	N/A	N/A	-3,018.12%	-191.88%	-166.43%	9/2/2026 (Estimated)
QTI QT Imaging	-$21.08M	-$1.24	N/A	N/A	N/A	-58.93%	-4,220.38%	-51.77%	8/6/2026 (Estimated)

Latest NXL, QTI, NEPH, and NTRB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	NEPH Nephros	$0.01	N/A	N/A	N/A	$4.99 million	N/A
8/6/2026	Q2 2026	QTI QT Imaging	-$0.22	N/A	N/A	N/A	$7.60 million	N/A
6/11/2026	Q1 2027	NTRB Nutriband	N/A	-$0.10	N/A	-$0.10	N/A	$0.43 million
5/13/2026	Q1 2026	QTI QT Imaging	-$0.1350	-$0.25	-$0.1150	-$0.25	$6.45 million	$6.53 million
5/8/2026	Q1 2026	NXL Nexalin Technology	-$0.10	-$0.11	-$0.01	-$0.11	$0.02 million	$0.01 million
5/7/2026	Q1 2026	NEPH Nephros	$0.01	$0.01	N/A	$0.01	$5.02 million	$5.21 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
NEPH Nephros	N/A	N/A	N/A	N/A	N/A
NTRB Nutriband	N/A	N/A	N/A	N/A	N/A
NXL Nexalin Technology	N/A	N/A	N/A	N/A	N/A
QTI QT Imaging	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
NEPH Nephros	N/A	4.55	3.12
NTRB Nutriband	N/A	5.26	5.11
NXL Nexalin Technology	N/A	4.07	3.85
QTI QT Imaging	1.38	2.49	1.69

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
NEPH Nephros	41.10%
NTRB Nutriband	19.70%
NXL Nexalin Technology	0.65%
QTI QT Imaging	24.19%

Insider Ownership

Company	Insider Ownership
NEPH Nephros	6.70%
NTRB Nutriband	52.21%
NXL Nexalin Technology	16.94%
QTI QT Imaging	25.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
NEPH Nephros	30	10.86 million	10.13 million	Not Optionable
NTRB Nutriband	10	12.16 million	5.81 million	Not Optionable
NXL Nexalin Technology	3	22.01 million	18.28 million	Not Optionable
QTI QT Imaging	N/A	13.77 million	10.27 million	N/A

NXL, QTI, NEPH, and NTRB Headlines

Recent News About These Companies

QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting

July 29, 2026 | finance.yahoo.com

QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer

July 29, 2026 | businesswire.com

QT Imaging Receives Israeli Ministry of Health Regulatory Registration

July 28, 2026 | businesswire.com

QT Imaging Announces Successful Completion of First FDA Routine Inspection with Zero Form 483 Observations

July 7, 2026 | businesswire.com

QT Imaging’s CEO Presents Sports Shiftmaker Award to Tennis Champion and Breast Cancer Survivor Martina Navratilova During Wimbledon Week

June 29, 2026 | finance.yahoo.com

A New Standard of Reproducibility for Quantitative Biomarkers in Breast Imaging

June 24, 2026 | businesswire.com

QT Imaging Receives Saudi Arabia FDA Regulatory Clearance

June 3, 2026 | businesswire.com

QT Imaging Set to Join the Russell Microcap® Index

May 28, 2026 | finance.yahoo.com

QT Imaging Holdings Announces Closing of $10 Million Underwritten Public Offering

May 18, 2026 | businesswire.com

QT Imaging Holdings Announces Pricing of $10 Million Underwritten Public Offering

May 16, 2026 | finance.yahoo.com

QT Imaging Holdings, Inc.

May 14, 2026 | edition.cnn.com

QT Imaging Holdings Inc (QTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...

May 14, 2026 | finance.yahoo.com

QT Imaging Holdings, Inc. (QTI) Q1 2026 Earnings Call Transcript

May 13, 2026 | seekingalpha.com

QT Imaging Holdings Q1 2026 Earnings Call: Complete Transcript

May 13, 2026 | finance.yahoo.com

QT Imaging Reports First Quarter 2026 Revenue of $6.5 Million

May 13, 2026 | businesswire.com

QT Imaging to Hold First Quarter 2026 Conference Call on May 13, 2026

May 6, 2026 | finance.yahoo.com

QT Imaging Debuts the QT Imaging-Olea Viewer for Integrated, Multimodality Breast Imaging Within a Single User Interface

April 15, 2026 | businesswire.com

QT Imaging Holdings Insider Trading Activity | NASDAQ:QTI | Benzinga

April 8, 2026 | benzinga.com

QT Imaging Holdings, Inc. Common Stock (QTI)

April 4, 2026 | nasdaq.com

QT Imaging CEO Discusses the Importance of Early Breast Cancer Detection at the Shiftmakers’ Panel and Gala

April 2, 2026 | gazettextra.comG

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXL, QTI, NEPH, and NTRB Company Descriptions

Nephros NASDAQ:NEPH

$3.51 +0.12 (+3.54%)

Closing price 04:00 PM Eastern

Extended Trading

$3.48 -0.03 (-0.85%)

As of 07:34 PM Eastern

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Nutriband NASDAQ:NTRB

$2.81 -0.04 (-1.40%)

Closing price 04:00 PM Eastern

Extended Trading

$2.82 +0.02 (+0.53%)

As of 07:34 PM Eastern

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Nexalin Technology NASDAQ:NXL

$0.36 +0.03 (+8.02%)

Closing price 04:00 PM Eastern

Extended Trading

$0.37 +0.00 (+1.12%)

As of 07:16 PM Eastern

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

QT Imaging NASDAQ:QTI

$2.63 -0.06 (-2.23%)

Closing price 04:00 PM Eastern

Extended Trading

$2.62 -0.01 (-0.57%)

As of 07:34 PM Eastern

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NXL, QTI, NEPH, and NTRB Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NXL, QTI, NEPH, and NTRB Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NXL, QTI, NEPH, and NTRB Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXL, QTI, NEPH, and NTRB Company Descriptions

Nephros NASDAQ:NEPH

Nutriband NASDAQ:NTRB

Nexalin Technology NASDAQ:NXL

QT Imaging NASDAQ:QTI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NXL, QTI, NEPH, and NTRB Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NXL, QTI, NEPH, and NTRB Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NXL, QTI, NEPH, and NTRB Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXL, QTI, NEPH, and NTRB Company Descriptions

Nephros NASDAQ:NEPH

Nutriband NASDAQ:NTRB

Nexalin Technology NASDAQ:NXL

QT Imaging NASDAQ:QTI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools